Government announces £4.75 million funding for Sequence ME research project

Good news!

This significant investment is an important milestone for a condition that has been historically neglected, despite its profound and long‑term impact on people’s health and quality of life. It reflects growing recognition that ME/CFS is a serious, complex biomedical illness requiring robust scientific investigation and evidence‑based approaches to management.

Building on the findings from DecodeME, the new SequenceME study should provide a deeper understanding of the underlying disease process, in particular how the immune and nervous systems respond to a triggering infection in ME/CFS.

For people with ME/CFS there is now real hope that we have a route to identifying a much‑needed diagnostic biomarker blood test and, ultimately, more effective and targeted forms of treatment.

»ME Association →